Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.25 USD | -1.63% | +15.56% | +66.94% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 395M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 67.5 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 66.1 x |
P/E ratio 2024 * |
-3.78
x | P/E ratio 2025 * |
-3.71
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.97% |
Latest transcript on Solid Biosciences Inc.
1 day | -1.63% | ||
1 week | +15.56% | ||
Current month | +15.56% | ||
1 month | -15.71% | ||
3 months | +41.38% | ||
6 months | +266.07% | ||
Current year | +66.94% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 10.25 | -1.63% | 106,212 |
24-05-07 | 10.42 | +4.20% | 174,822 |
24-05-06 | 10 | -0.99% | 173,603 |
24-05-03 | 10.1 | -1.27% | 674,823 |
24-05-02 | 10.23 | +7.23% | 267,252 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.94% | 395M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- SLDB Stock